NasdaqGS:SPNE

Stock Analysis Report

Executive Summary

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally.

Snowflake

Fundamentals

Flawless balance sheet and overvalued.


Similar Companies

Share Price & News

How has SeaSpine Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

15.1%

NasdaqGS:SPNE

-1.2%

US Medical Equipment

1.2%

US Market


1 Year Return

-20.4%

NasdaqGS:SPNE

8.7%

US Medical Equipment

1.7%

US Market

SPNE underperformed the Medical Equipment industry which returned 8.7% over the past year.

SPNE underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

SPNEIndustryMarket
7 Day15.1%-1.2%1.2%
30 Day17.7%1.4%4.9%
90 Day-6.8%4.8%3.7%
1 Year-20.4%-20.4%9.6%8.7%3.9%1.7%
3 Year27.0%27.0%70.8%65.5%47.2%37.7%
5 Yearn/a130.4%104.1%60.0%42.4%

Price Volatility Vs. Market

How volatile is SeaSpine Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is SeaSpine Holdings undervalued based on future cash flows and its price relative to the stock market?

1.94x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for SeaSpine Holdings to establish if it is available at moderate discount.

Unable to calculate intrinsic value for SeaSpine Holdings to establish if it is available at substantial discount.


Price Based on Earnings

SeaSpine Holdings is loss making, we can't compare its value to the US Medical Equipment industry average.

SeaSpine Holdings is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for SeaSpine Holdings, we can't assess if its growth is good value.


Price Based on Value of Assets

SeaSpine Holdings is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is SeaSpine Holdings expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

19.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

SeaSpine Holdings's revenue is expected to grow by 7.6% yearly, however this is not considered high growth (20% yearly).

SeaSpine Holdings is not considered high growth as it is expected to be loss making for the next 1-3 years.

SeaSpine Holdings's revenue growth is expected to exceed the United States of America market average.

Unable to compare SeaSpine Holdings's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare SeaSpine Holdings's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if SeaSpine Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has SeaSpine Holdings performed over the past 5 years?

5.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

SeaSpine Holdings does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare SeaSpine Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare SeaSpine Holdings's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if SeaSpine Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if SeaSpine Holdings has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if SeaSpine Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is SeaSpine Holdings's financial position?


Financial Position Analysis

SeaSpine Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

SeaSpine Holdings's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

SeaSpine Holdings has no debt.

SeaSpine Holdings currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet

High level of physical assets or inventory.

SeaSpine Holdings has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

SeaSpine Holdings has sufficient cash runway for 1.3 years based on current free cash flow.

SeaSpine Holdings has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 2.3% each year.


Next Steps

Dividend

What is SeaSpine Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate SeaSpine Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate SeaSpine Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as SeaSpine Holdings has not reported any payouts.

Unable to verify if SeaSpine Holdings's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as SeaSpine Holdings has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of SeaSpine Holdings's salary, the management and board of directors tenure and is there insider trading?

4.2yrs

Average management tenure


CEO

Keith Valentine (51yo)

4.3yrs

Tenure

US$1,990,645

Compensation

Mr. Keith C. Valentine has been the Chief Executive Officer of SeaSpine Holdings Corporation since June 2015 and has been its President since June 2015. Mr. Valentine served as Special Advisor to the Chief ...


CEO Compensation Analysis

Keith's remuneration is higher than average for companies of similar size in United States of America.

Keith's compensation has increased whilst company is loss making.


Management Age and Tenure

4.2yrs

Average Tenure

50yo

Average Age

The tenure for the SeaSpine Holdings management team is about average.


Board Age and Tenure

4.2yrs

Average Tenure

56yo

Average Age

The tenure for the SeaSpine Holdings board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Keith Valentine (51yo)

    President

    • Tenure: 4.3yrs
    • Compensation: US$1.99m
  • Tyler Lipschultz (52yo)

    Senior Vice President of Orthobiologics & Business Development

    • Tenure: 1.6yrs
    • Compensation: US$996.47k
  • Pat Keran (47yo)

    VP, General Counsel & Secretary

    • Tenure: 3.9yrs
    • Compensation: US$868.49k
  • John Bostjancic (48yo)

    Senior VP

    • Tenure: 4.5yrs
    • Compensation: US$1.01m
  • Dennis Cirino (49yo)

    Senior Vice President of Global Spinal Systems

    • Tenure: 1.2yrs
  • John Winge (52yo)

    Vice President of Sales

    • Tenure: 4.3yrs
    • Compensation: US$724.07k
  • Paul Benny

    Vice President

    • Tenure: 4.2yrs
  • Carrie Mendivil

    Head of Investor Relations

    • Tenure: 0yrs

Board Members

  • Jack Henneman (57yo)

    Director

    • Tenure: 4.2yrs
    • Compensation: US$150.00k
  • Stuart Essig (57yo)

    Lead Independent Director

    • Tenure: 4.2yrs
    • Compensation: US$190.00k
  • Keith N. Bradley (74yo)

    Director

    • Tenure: 4.2yrs
    • Compensation: US$150.00k
  • Keith Valentine (51yo)

    President

    • Tenure: 4.3yrs
    • Compensation: US$1.99m
  • Mike Fekete (55yo)

    Director

    • Tenure: 4.2yrs
    • Compensation: US$165.00k
  • Kirt Stephenson (60yo)

    Non-Executive Chairman

    • Tenure: 4.2yrs
    • Compensation: US$225.00k
  • Kim Commins-Tzoumakas (51yo)

    Director

    • Tenure: 0.6yrs
  • Renee M. Gaeta (38yo)

    Director

    • Tenure: 0.6yrs

Company Information

SeaSpine Holdings Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: SeaSpine Holdings Corporation
  • Ticker: SPNE
  • Exchange: NasdaqGS
  • Founded: 2015
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$241.046m
  • Shares outstanding: 19.06m
  • Website: https://www.seaspine.com

Number of Employees


Location

  • SeaSpine Holdings Corporation
  • 5770 Armada Drive
  • Carlsbad
  • California
  • 92008
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SPNENasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJun 2015
46LBST (Boerse-Stuttgart)YesCommon StockDEEURJun 2015

Biography

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and i ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 01:26
End of Day Share Price2019/09/13 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.